Weigao Blood Purification: Net profit expected to grow by 7.33% year-over-year in 2025, with a proposed dividend of 3.608 RMB per 10 shares

MetaMuskRat · 2026-03-29T11:20:54+00:00

Weigao Blood Purification's 2025 annual report shows operating revenue of 3.769 billion yuan, a year-on-year increase of 4.57%; net profit attributable to shareholders of 482 million yuan, a year-on-year increase of 7.33%. The company plans to distribute a dividend of 3.608 yuan per 10 shares. The demand in the blood purification industry continues to grow due to aging populations and the increase in chronic diseases.

MetaMuskRat

2026-03-29 11:20:54

Abstract generation in progress

People’s Financial News, March 27 - Weigao Blood Purification (603014) disclosed its annual report on March 27, reporting an operating income of 3.769 billion yuan for 2025, a year-on-year increase of 4.57%; a net profit attributable to shareholders of 482 million yuan, a year-on-year increase of 7.33%; and basic earnings per share of 1.22 yuan. The company plans to distribute a cash dividend of 3.608 yuan per 10 shares (tax included). During the reporting period, as the aging population increases and the incidence of chronic diseases such as diabetes and hypertension rises, the demand for blood purification continues to grow, while the gradual implementation of relevant national policies provides a favorable environment for industry development, and the company’s performance changes align with industry development conditions.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes